VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Jazz Pharmaceuticals plc (JAZZ) Total Return Calculator with Dividends Reinvested

Jazz Pharmaceuticals plc

Popular:

The total return for Jazz Pharmaceuticals plc (JAZZ) stock is +105.60% over the past 12 months. So far it's up 32.01% this year. The 5-year total return is +32.24%, meaning $10,000 invested in JAZZ stock 5 years ago would be worth $13,224 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in JAZZ 1 year ago, it would be worth $22,533 today — you'd have gained $12,533.

With Dividends Reinvested$22,533+125.33%

Price Only (No DRIP)$22,533+125.33%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in JAZZ

1Y$20,560+$10,560 (+105.6%)105.6% CAGR

3Y$16,482+$6,482 (+64.8%)18.1% CAGR

5Y$13,224+$3,224 (+32.2%)5.7% CAGR

10Y$15,834+$5,834 (+58.3%)4.7% CAGR

15Y$78,091+$68,091 (+680.9%)14.7% CAGR

20Y$128,917+$118,917 (+1189.2%)13.6% CAGR

30Y$128,917+$118,917 (+1189.2%)8.9% CAGR

Jazz Pharmaceuticals plc did not pay dividends during this period. Total return = price return.

Loading JAZZ total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+32.01%	—	+32.01%	—	$13,201
1Y	+105.60%	105.60%	+105.60%	—	$20,560
3Y	+64.82%	18.12%	+64.82%	—	$16,482
5Y	+32.24%	5.75%	+32.24%	—	$13,224
10Y	+58.34%	4.70%	+58.34%	—	$15,834
15Y	+680.91%	14.69%	+680.91%	—	$78,091
20Y	+1189.17%	13.64%	+1189.17%	—	$128,917
30Y	+1189.17%	8.90%	+1189.17%	—	$128,917

Risk & Highlights

Best Year+294.00%2009

Worst Year-86.96%2008

Max Drawdown-18.55%2025-05-06 → 2025-05-09 · Recovered 2025-06-09

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+9.74%	+9.74%	—	+0.41%	+9.3pp
2025	+37.36%	+37.36%	—	+16.64%	+20.7pp
2024	-2.98%	-2.98%	—	+24.00%	-27.0pp
2023	-21.34%	-21.34%	—	+24.81%	-46.1pp
2022	+21.60%	+21.60%	—	-19.95%	+41.5pp

JAZZ outperformed the S&P 500 by 74.28pp over the past year (+105.60% vs +31.32%).

Loading summary...

JAZZ Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
JAZZJazz Pharmaceuticals plc	$14.3B	+22.3%	+32.0%	+105.6%	—	+64.8%	+32.2%	+58.3%
SUPNSupernus Pharmaceuticals, Inc.	$3.0B	+1.8%	+4.0%	+58.6%	—	+39.8%	+75.7%	+240.3%
PCRXPacira BioSciences, Inc.	$932M	+6.4%	-3.1%	-5.8%	—	-43.9%	-62.5%	-50.0%
INVAInnoviva, Inc.	$1.9B	-2.2%	+13.3%	+20.4%	—	+92.8%	+95.5%	+90.5%
AVNSAvanos Medical, Inc.	$1.2B	+78.7%	+121.1%	+92.4%	—	+5.4%	-42.3%	-15.7%
PRGOPerrigo Company plc	$1.7B	+15.8%	-9.6%	-45.6%	+4.7pp	-56.6%	-58.6%	-76.8%
ALKSAlkermes plc	$5.9B	+3.6%	+25.0%	+16.3%	—	+14.3%	+60.5%	-7.7%
INCYIncyte Corporation	$19.9B	+5.3%	-1.5%	+67.5%	—	+51.8%	+21.3%	+41.3%
HALOHalozyme Therapeutics, Inc.	$7.8B	+5.2%	-5.6%	+11.7%	—	+119.1%	+39.1%	+598.4%
ACADACADIA Pharmaceuticals Inc.	$3.7B	-3.8%	-17.9%	+47.7%	—	-0.3%	+2.5%	-22.3%
AVPTAvePoint, Inc.	$2.2B	+2.4%	-22.3%	-39.5%	—	+131.8%	+1.1%	+5.0%

Compare:JAZZ vs SUPN JAZZ vs PCRX JAZZ vs INVA JAZZ vs SUPN vs PCRX

About JAZZ Dividend Returns

Jazz Pharmaceuticals plc (JAZZ) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of JAZZ over the past year?

Jazz Pharmaceuticals plc (JAZZ) delivered a return of 105.60% over the past year. Since JAZZ does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in JAZZ be worth today?

A $10,000 investment in Jazz Pharmaceuticals plc one year ago would be worth $20,560 today, representing a gain of $10,560.

Q3Does JAZZ pay dividends?

Jazz Pharmaceuticals plc (JAZZ) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For JAZZ, the total return equals the price-only return.

Q4Did JAZZ beat the S&P 500?

Yes, Jazz Pharmaceuticals plc (JAZZ) outperformed the S&P 500 by 74.28 percentage points over the past year. JAZZ delivered a total return of 105.60%, compared to the S&P 500's 31.32%. This 74.28pp alpha means investors in JAZZ earned more than a passive S&P 500 index fund.

Q5What is JAZZ's worst drawdown?

Jazz Pharmaceuticals plc (JAZZ) experienced a maximum drawdown of -18.55% over the past year, declining from its peak on 2025-05-06 to its trough on 2025-05-09. The stock recovered to its prior peak by 2025-06-09. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is JAZZ's long-term total return over 10, 20, or 30 years?

Here are Jazz Pharmaceuticals plc (JAZZ)'s long-term returns with dividends reinvested. Over 10 years, the total return is 58.3% (4.7% CAGR) — $10,000 would have grown to $15,834. Over 20 years: 1189.2% total return (13.6% CAGR) — $10,000 → $128,917. Over 30 years: 1189.2% total return (8.9% CAGR) — $10,000 → $128,917. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was JAZZ's best and worst year?

Jazz Pharmaceuticals plc's best calendar year was 2009 with a total return of 294.0%. Its worst year was 2008 with a total return of -87.0%. This range shows the volatility investors should expect — the difference between the best and worst year is 381.0 percentage points.